Pharmacokinetic and Pharmacodynamic Effects of Passive Cannabis Inhalation
Completed · Phase 1
Conditions studied: Cannabis Toxicology
In brief
This primary aim of this study is to assess the effects of passive (second-hand) inhalation of cannabis smoke on toxicological analysis of "native" oral fluid (saliva), urine and blood specimens. The results of this study will help inform the validity of oral fluid as a biomarker of cannabis exposure and to determine whether, and for how long, passive inhalation of cannabis smoke could result in a positive toxicology result.
Key facts
- Study ID
- NCT01798186
- Run by
- Johns Hopkins University
- People needed
- 26
- Starts
- 2013-05-01
- Expected to finish
- 2013-08-01
- Last updated by the study team
- 2017-08-03
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.
Where it is running
- Johns Hopkins Behavioral Pharmacology Research Unit — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.